Teledyne Technologies Faces Accelerating Organic Growth Prospects, UBS Says

MT Newswires Live12-11

Teledyne Technologies' (TDY) healthy book-to-bill rates and a positive organic sales inflection in Q3 spurred optimism on growth prospects, UBS Securities said Tuesday in a report.

"We see a strengthening outlook for short cycle activity in 2025, and we think accelerating organic growth will restore sentiment and support multiple rerating," the firm said.

UBS resumed coverage of Teledyne with a buy rating and $585 price target, up from $525.

Despite the company's "strong track record of compounding growth via M&A driving consistent double-digit [earnings per share] growth," the stock currently trades at a relative discount to peers and historical valuation, the report said.

UBS forecast a 6% compound annual growth rate in sales through 2026, compared with the consensus estimate of 5%.

Price: 473.29, Change: +2.55, Percent Change: +0.54

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment